Propanc Biopharma, Inc. Common Stock Long-term Investment Intensity
Propanc Biopharma, Inc. Common Stock long-term investment intensity. Propanc Biopharma, Inc. Common Stock (PPCB) has a Long-term Investment Intensity of 0.8% as of March 2019. Long-term investments of $2.13K represent 0.8% of total assets of $259.92K. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Propanc Biopharma, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Propanc Biopharma, Inc. Common Stock Long-term Investment Intensity by Year (None–None)
Propanc Biopharma, Inc. Common Stock long-term investment intensity by year from None to None. The table below presents the year-by-year Long-term Investment Intensity for Propanc Biopharma, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Propanc Biopharma, Inc. Common Stock's balance sheet.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|